Machine learning models to predict ICU admission of patients with COPD and depression: A retrospective cohort study
Clinical Snapshot
PICO Framework
| P — Population | Adult patients with comorbid COPD and depression admitted to hospital for the first time, identified from the MIMIC-IV version 3.1 database |
| I — Intervention | Machine learning-based predictive modelling using 16 clinically derived features selected via the Boruta algorithm (including AKI, sepsis, invasive ventilation, and anemia-related indices) |
| C — Comparator | Comparison of five ML algorithms (including Random Forest) against each other; no comparison to an established clinical prediction rule or validated prognostic score |
| O — Outcomes | ICU admission (binary outcome); model performance assessed by AUC-ROC, calibration curves, decision curve analysis, sensitivity, specificity, PPV, NPV, F1 score, and SHAP-based feature importance |
Bottom Line
This retrospective study used MIMIC-IV data to develop ML models predicting ICU admission in 1,121 patients with comorbid COPD and depression. The Random Forest model demonstrated strong internal discriminative performance (sensitivity 0.853, specificity 0.948, balanced accuracy 0.901), with AKI, sepsis, and invasive ventilation emerging as the dominant predictors via SHAP analysis — findings that are clinically plausible but not surprising. The study's principal strength lies in its use of a large, well-characterised database and its application of interpretable ML methods. However, critical methodological gaps substantially limit its clinical utility: there is no external validation, no comparison to established prognostic scores, no confidence intervals reported, and no operationalised decision threshold. The model is derived from a single US academic centre and cannot be assumed to generalise to Australian or other health systems. Clinicians should regard these findings as hypothesis-generating rather than practice-changing. The identification of anemia-related indices as secondary predictors warrants further investigation. Before this or any similar ML tool could be considered for clinical deployment in Australian acute care settings, prospective external validation in diverse populations, comparison against existing triage scores, and regulatory review would be essential.
Key Findings
P Value: Not reported in abstract
Effect Size: Random Forest model: sensitivity 0.853, specificity 0.948, PPV 0.924, NPV 0.898, F1 score 0.887, balanced accuracy 0.901. Top SHAP predictors: AKI (mean |SHAP| 0.212), sepsis (0.092), invasive ventilation (0.073), hemoglobin (0.023), haematocrit (0.023), MCHC (0.022)
Primary Outcome: ICU admission among patients with comorbid COPD and depression (n=1121 first-time hospitalisations from MIMIC-IV v3.1)
Nnt Or Sensitivity: Sensitivity (recall) 0.853 for ICU admission prediction; specificity 0.948; AUC not explicitly stated in abstract but implied to be high given balanced accuracy of 0.901
Confidence Interval: Not reported for any performance metric
Clinical Application
The 16 predictor variables are largely derived from routine admission blood tests and clinical documentation, making data collection feasible in most acute care settings. However, the model is not operationalised as a bedside tool, no risk threshold is defined, and implementation would require prospective validation and integration into clinical workflows. The model is not currently available as a validated clinical decision support tool. COPD affects approximately 1 in 13 Australians aged 45 and over (AIHW), and depression is a recognised comorbidity associated with worse outcomes. Australian COPD management is guided by RACGP and Lung Foundation Australia guidelines, which do not currently incorporate ML-based ICU triage tools. The MIMIC-IV database reflects US tertiary-care practice, which differs from Australian public hospital systems in ICU admission thresholds, staffing ratios, and care escalation norms. PBS-listed therapies for COPD (e.g., long-acting bronchodilators, inhaled corticosteroids) and antidepressants are not captured in this model. TGA approval and RACGP endorsement would be prerequisites before any such tool could be considered for Australian clinical use. The findings regarding AKI, sepsis, and invasive ventilation as dominant ICU admission predictors are clinically consistent with Australian critical care practice and may inform risk stratification discussions, but the model itself cannot be directly applied without local validation. Hospitalised adults with confirmed comorbid COPD and depression, particularly those presenting with AKI, sepsis, or requiring invasive ventilation, in tertiary-care settings with access to routine biochemical and haematological data
Abstract
This study aimed to develop and validate a machine learning (ML)-based predictive model to identify risk factors associated with intensive care unit (ICU) admission among patients with comorbid Chronic Obstructive Pulmonary Disease (COPD) and depression. Data of patients diagnosed with both COPD and depression were extracted from the MIMIC-IV version 3.1 database. A total of 1121 patients with first-time hospitalization and comorbid COPD and depression were included. Feature selection was performed using the Boruta algorithm. Five ML algorithms were employed to construct prediction models. Model performance was evaluated using the receiver operating characteristic curve, area under the curve, calibration curves, and decision curve analysis. Shapley additive explanations (SHAP) plots were used to interpret the contribution of each feature to the model's predictions. Sixteen variables identified by the Boruta algorithm were used to build the predictive models, including chloride, prothrombin time, phosphorus, bicarbonate, international normalized ratio, mean corpuscular hemoglobin (MCH) concentration (MCHC), mean corpuscular hemoglobin, hemoglobin, hematocrit (HCT), total calcium, paraplegia, cerebrovascular disease, smoker status, invasivevent, sepsis, and acute kidney injury (AKI). The Random Forest model performed the best: specificity (0.948), positive predictive value (0.924), precision (0.924), F1 score (0.887), balanced accuracy (0.901), sensitivity (0.853), negative predictive value (0.898), and recall (0.853). SHAP analysis indicated that AKI (0.212), sepsis (0.092), and invasivevent (0.073) were the most influential predictors, followed by anemia-related features such as hemoglobin (0.023), HCT (0.023), and MCHC (0.022). ML analysis revealed that AKI, sepsis, invasivevent, and anemia-related indicators are key risk factors for ICU admission among COPD patients with depression. However, it is important to note that the findings lack external validation, which warrants further investigation in diverse patient populations.
References
- 1.Chen, H., Guo, Y., You, T., & Shi, K. (2026). Machine learning models to predict ICU admission of patients with COPD and depression: A retrospective cohort study. Medicine. https://doi.org/10.1097/MD.0000000000049519
Related Research
Sleep medicine reviews
Artificial intelligence in sleep medicine I: Diagnosis, treatment, care, and research
2 Aug 2026
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Shorter Antitubercular Regimens Versus 9 Months of Isoniazid for Latent Tuberculosis in Children: A Systematic Review and Meta-Analysis
25 July 2026
Pulmonology
Systematic review of prognostic scores and individual predictor variables for short-term mortality after acute pulmonary embolism.
17 July 2026
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service